Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Department of Physiology, Anatomy & Genetics (DPAG) scientists develop single-cell oxygen saturation imaging to study oxygen handling by red blood cells. New physiological techniques that measure the blood's oxygen saturation are particularly important in light of the current pandemic, as COVID-19 patients present an abnormally low concentration of oxygen in the blood.

Oxygen saturation of blood is a fundamental clinical parameter that assesses how much oxygen is being carried by red blood cells (RBCs). The importance of these so-called oximetery measurements is highlighted by the current COVID-19 crisis because patients present a profound drop in blood oxygen, known as hypoxaemia. However, another aspect of oxygen handling by blood that is not currently measured is the speed with which RBCs exchange gases. Indeed, routinely performed tests for gas-carrying capacity (for example, total hemoglobin) cannot determine how fast RBCs take-up and release oxygen. Such information is critical for evaluating the physiological fitness of RBCs, which have less than one second to exchange large volumes of oxygen in the lungs and tissues.

To address this problem, a team led by Associate Professor Pawel Swietach has designed a method to quantify gas exchange in individual RBCs. Applying this method to various blood disorders has highlighted the barriers to efficient gas exchange. The results identify the adaptations that allow healthy RBCs to exchange gases quickly, and explain how disease-related changes may impair oxygen transport.

Read the full story on the Department of Physiology, Anatomy & Genetics (DPAG) website

Similar stories

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.

COVID-19’s high blood clot risk

A recent study of patient health records found that around 1 in 100 people with COVID-19 had a venal or arterial thrombosis, with rates higher still among males, and particularly for those hospitalised.

Medical Sciences Division receives REF 2021 results

Today the UK Funding Bodies have published the outcomes of the recent national research assessment exercise, the Research Excellence Framework (REF) 2021. REF is the UK-wide assessment of research in universities, and provides an expert evaluation of the quality of the research outputs, impact and environment at subject level in each university.